100 Migraine drugs, A to Z: acetazolamide

April 18, 2018

This is the first in a 100-part series of blogs on various migraine drugs. Yes, we do use that many drugs to treat migraines, although only a handful are FDA-approved for migraines. Many of these drugs are in the same family, but they are all somewhat different from each other.

Acetazolamide (Diamox) is a diuretic (water pill), which is used to treat mountain sickness. Unlike other diuretics, it is somewhat selective in removing extra fluid from the brain and the lungs, rather than equally from all parts of the body.

Migraine sufferers whose migraines are triggered by traveling to high altitudes can sometimes prevent these migraines by taking acetazolamide the day before their ascent and then throughout their stay at high altitude. A handful of my patients continued to take acetazolamide even after they returned to the sea level because they found it to be effective in preventing all of their migraines. These patients tended to have barometric pressure changes as their main migraine trigger. For people who get only occasional weather-related headaches, taking acetazolamide daily is not necessary. However, they can often prevent an attack by taking the drug the day barometric pressure drops and for as long as the pressure fluctuates.

To avoid having to constantly watch the weather forecast, a couple of apps can send you a warning whenever barometric pressure drops (it usually takes a drop of 20 millibars of pressure to trigger a migraine). One such free app is MigraineX.

Interestingly, people who live at high altitudes tend to have more migraines than those living aa the sea level.

Acetazolamide is also used to treat headaches due to increased intracranial pressure (pressure inside the skull).

Acetazolamide is available in 125 mg, 250 mg, and an extended release, 500 mg tablets. The usual starting dose is 250 mg once a day. Potential side effects include tingling of your face and extremities, dizziness, altered taste (carbonated beverages have a very unpleasant taste), and with long-term daily use, kidney stones.

Written by
Alexander Mauskop, MD
Continue reading
June 24, 2026
Fast Walkers Have Better Brain Health into their 80s
Taken together, the super mover data strengthen a simple, clinically useful message: how our oldest patients walk tells us a great deal about how their brains are aging. Fast, confident gait in the ninth decade is not just reassuring from a mobility standpoint; it signals cognitive resilience built on decades of better vascular health, regular physical activity, and supportive environments. For headache and neurology patients, this research offers one more reason to invest in walking, strength, balance, sleep, mood, and lifestyle change: protecting gait speed into late life may be one of the most practical ways to protect thinking and memory as well.
Read article
June 21, 2026
Research
Childhood Stress Rewrites the Body's Metabolism
Two new papers—one in Science and one in Biological Psychiatry—offer a more biologically grounded way to think about the long-term impact of early life stress. Rather than acting only at the psychological level, early adversity appears to leave lasting marks on both the epigenome and mitochondrial function. These findings suggest that early experience may help shape core aspects of cellular energy metabolism, a pathway already central to how we understand migraine.
Read article
June 17, 2026
Research
A New Controlled Trial Suggests Even a Short Behavioral Treatment Can BeEffective for Chronic Pain
A new randomized controlled trial in PAIN found that just six 30-minute CBT sessions for chronic musculoskeletal pain significantly reduced pain interference and improved sleep and physical quality of life, with benefits sustained at follow-up. The findings suggest that brief, scalable behavioral treatments could be integrated into routine primary care and headache practice to improve function without requiring long-term psychotherapy.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe